ヒト個人識別市場規模、シェア、動向、2031年までの世界予測

世界のヒト個人識別市場は、2026年の10億1,000万米ドルから2031年には16億9,000万米ドルに達するとMarketsandMarketsでは予測されており、2026年から2031年までの年平均成長率（CAGR）は10.9%です。この世界的な個人識別市場の拡大は、法医学事件の未処理件数の増加やデータベースの拡張、そして警察署における迅速DNA検査の導入によって促進されています。

調査概要：

本調査レポートは、世界のヒト個人識別市場を、製品（消耗品、機器、ソフトウェア）、技術（ポリメラーゼ連鎖反応、キャピラリー電気泳動、次世代シーケンシング、マイクロアレイ、迅速DNA分析）、用途（法医学用途、親子鑑定、その他の用途）、エンドユーザー（法医学研究所、研究センター、学術機関・政府機関、その他のエンドユーザー）、地域（北米、欧州、アジア太平洋、ラテンアメリカ、中東、アフリカ）別に分類しています。

本レポートでは、ヒト個人識別市場の成長に影響を与える主要な要因（推進要因、阻害要因、課題、機会など）に関する詳細な情報を提供しています。また、主要企業について、事業概要、製品、ソリューション、主要戦略、提携、パートナーシップ、契約に関する詳細な分析を実施しています。

本レポートを購入する主なメリット：

本レポートは、ヒト個人識別市場全体およびそのサブセグメントにおける収益の最も正確な予測値を提供することで、市場リーダー企業と新規参入企業を支援します。また、関係者が競争環境をより深く理解し、事業のポジショニングを改善し、適切な市場参入戦略を策定するための洞察を得るのに役立ちます。さらに、本レポートは、市場の動向を把握し、主要な推進要因、阻害要因、機会、課題に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します。

主要な推進要因（法医学事件のバックログの増加とDNAデータベースの拡大、予約センターにおける迅速DNA技術の導入、複雑な事件処理およびDVIにおけるNGSへの移行、認証および品質基準（ISO 17025）の強化）、制約要因（政府予算の制約と法医学資金、CEおよびPCRシステムの更新サイクルの遅さ、STRキットの価格圧力、一部地域における迅速DNAの規制上の受容度の低さ）、機会（確率的遺伝子型判定の導入、抽出ワークフローの自動化、血縁関係および法医学的系譜学のためのNGSパネルの拡大、新興市場における法医学インフラの構築）、および課題（直接PCRキットによる試薬使用量の減少、CEからNGSへの移行によるCEの優位性の低下、法的課題／プライバシーに関する懸念、NGSの検証および認証の高コスト）。

• 製品開発／イノベーション：世界のヒト識別市場における今後の技術および研究開発活動に関する詳細な洞察。
• 市場開発：有望な市場に関する包括的な情報。本レポートは、様々な地域における市場を分析しています。
• 市場の多様化：未開拓地域、最新の動向、および世界のヒト個人識別市場への投資に関する詳細な情報。
• 競合評価：主要企業の市場シェア、成長戦略、および製品提供に関する詳細な評価。主要業界プレーヤーの詳細な分析を行い、主要戦略、製品の発売/承認、買収、パートナーシップ、契約、協力、その他の最新の動向、投資および資金調達活動、ブランド/製品の比較分析、および世界のヒト識別市場におけるベンダー評価と財務指標に関する洞察を提供します。

Report Description

The global human identification market is projected to reach USD 1.69 billion by 2031 from USD 1.01 billion in 2026, at a CAGR of 10.9% from 2026 to 2031. The expansion of the global human identification market has been fueled by rising forensic case backlogs and databank expansions, as well as the adoption of rapid DNA testing in booking stations.

In 2025, the DNA amplification kits & reagents segment held the largest share of the global human identification consumables market.

The consumables market is segmented into DNA amplification kits & reagents, rapid DNA analysis kits & reagents, DNA quantification kits & reagents, and DNA extraction kits & reagents. The DNA amplification kits & reagents segment held the largest share of the consumables market due to their central role in STR-based DNA profiling workflows, which remain the gold standard in forensic and paternity testing applications. These kits are required for every DNA sample processed, making them the most frequently used consumables across laboratories. Additionally, the large share is driven by the widespread adoption of validated STR kits in national DNA databases (such as CODIS), the increasing volume of forensic casework, and the need for high-throughput, reliable DNA amplification across various sample types. Compared to other consumables, amplification kits carry a higher per-test value and recurring demand, further contributing to their leading market position.

“The sample preparation & extraction segment accounted for the largest share of the global human identification instruments market in 2025.”

Within the instruments segment, the global human identification market is divided into sample preparation & extraction systems, DNA amplification systems, DNA analysis systems, and DNA quantification systems. In 2025, sample preparation & extraction systems accounted for the largest share of the global human identification instruments market. The dominance of this segment is mainly due to the critical role of DNA extraction as the first and essential step in all DNA analysis workflows, where high-quality and contaminant-free DNA is required for accurate downstream results.

The APAC registered the highest CAGR from 2026 to 2031.

The human identification market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The APAC region is projected to grow at the highest CAGR during the forecast period. This surge is driven by the rapid expansion of healthcare infrastructure in China, India, and Japan, alongside rising crime rates, an increasing number of forensic laboratories, and the implementation of awareness campaigns and conferences on human identification and forensic sciences.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side (70%) and Demand Side (30%)
• By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
• By Region: North America (40%), Europe (25%), the Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

List of Key Companies Profiled in the Report:

Key players in the global human identification market include Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Promega Corporation (US), Hamilton Company (US), ANDE Corporation (US), FUJIFILM Wako Pure Chemical Corporation (Japan), AutoGen Inc. (US), InnoGenomics Technologies, LLC (US), Oxford Nanopore Technologies Plc (UK), Bode Cellmark Forensics Inc. (US), Bio-Rad Laboratories, Inc. (US), ZEISS (Germany), Cybergenetics, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and BIOTYPE GmbH (Germany).

Research Coverage:

This research report categorizes the global human identification market by product (consumables, instruments, and software), technology (polymerase chain reaction, capillary electrophoresis, next-generation sequencing, microarrays, and rapid DNA analysis), application (forensic applications, paternity testing, and other applications), end user (forensic laboratories, research centers and academic & government institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the human identification market. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products, solutions, key strategies, collaborations, partnerships, and agreements.

Key Benefits of Buying the Report:

The report will help market leaders and new entrants by providing the closest approximations of revenue for the overall human identification market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide information on key drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

• Analysis of key drivers [rising forensic case backlog and expansion of DNA databases, adoption of rapid DNA technologies in booking stations, transition toward NGS in complex casework & DVI, and increased accreditation & quality standards (ISO 17025)], restraints (government budget constraints & forensic funding, slow replacement cycle of CE & PCR systems, price pressure on STR kits, and limited rapid DNA regulatory acceptance in some regions), opportunities (probabilistic genotyping adoption, automation of extraction workflows, NGS panel expansion for kinship & forensic genealogy, and emerging market forensic infrastructure build-out), and challenges (declining reagent usage due to direct-PCR kits, migration from CE to NGS reduces CE dominance, legal challenges/privacy concerns, and high cost of NGS validation & accreditation).
• Product Development/Innovation: Detailed insights on upcoming technologies and research & development activities in the global human identification market.
• Market Development: Comprehensive information about lucrative markets. The report analyzes the market across varied regions.
• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the global human identification market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/approvals, acquisitions, partnerships, agreements, collaborations, other recent developments, investments & funding activities, brand/product comparative analysis, and vendor valuation & financial metrics of the global human identification market.

Table of Contents

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 35
1.4 INCLUSIONS & EXCLUSIONS 36
1.4.1 YEARS CONSIDERED 36
1.4.2 CURRENCY CONSIDERED 37
1.5 STAKEHOLDERS 37
1.6 SUMMARY OF CHANGES 37
2 EXECUTIVE SUMMARY 39
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 39
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 41
2.3 DISRUPTIVE TRENDS IN HUMAN IDENTIFICATION MARKET 42
2.4 HIGH-GROWTH SEGMENTS 43
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 44
3 PREMIUM INSIGHTS 45
3.1 HUMAN IDENTIFICATION MARKET OVERVIEW 45
3.2 NORTH AMERICA: HUMAN IDENTIFICATION MARKET, BY PRODUCT 46
3.3 HUMAN IDENTIFICATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
3.4 HUMAN IDENTIFICATION MARKET SHARE, BY END USER, 2026 VS. 2031 (%) 47
4 MARKET OVERVIEW 48
4.1 INTRODUCTION 48
4.2 MARKET DYNAMICS 48
4.2.1 DRIVERS 49
4.2.1.1 Rising forensic case backlog and expansion of DNA databases 49
4.2.1.2 Adoption of rapid DNA technologies in booking stations 50
4.2.1.3 Transition toward NGS in complex casework & DVI 51
4.2.1.4 Increased accreditation & quality standards (ISO 17025) 51
4.2.2 RESTRAINTS 51
4.2.2.1 Government budget constraints & forensic funding 51
4.2.2.2 Slow replacement cycle of CE & PCR systems 52
4.2.2.3 Price pressure on STR kits 52
4.2.2.4 Limited rapid DNA regulatory acceptance in some regions 52

4.2.3 OPPORTUNITIES 53
4.2.3.1 Probabilistic genotyping adoption 53
4.2.3.2 Automation of extraction workflows 53
4.2.3.3 NGS panel expansion for kinship & forensic genealogy 53
4.2.3.4 Emerging market forensic infrastructure build-out 54
4.2.4 CHALLENGES 54
4.2.4.1 Declining reagent usage due to direct-PCR kits 54
4.2.4.2 Migration from CE to NGS reduces CE dominance 55
4.2.4.3 Legal challenges/privacy concerns 55
4.2.4.4 High cost of NGS validation & accreditation 55
4.3 UNMET NEEDS & WHITE SPACES 56
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 57
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 59
5 INDUSTRY TRENDS 60
5.1 PORTER’S FIVE FORCES ANALYSIS 60
5.1.1 THREAT OF NEW ENTRANTS 61
5.1.2 THREAT OF SUBSTITUTES 61
5.1.3 BARGAINING POWER OF BUYERS 61
5.1.4 BARGAINING POWER OF SUPPLIERS 61
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.2 MACROECONOMIC OUTLOOK 62
5.2.1 INTRODUCTION 62
5.2.2 GDP TRENDS & FORECAST 62
5.2.3 TRENDS IN GLOBAL HUMAN IDENTIFICATION MARKET 62
5.2.4 TRENDS IN HEALTHCARE EXPENDITURE 63
5.3 VALUE CHAIN ANALYSIS 65
5.4 SUPPLY CHAIN ANALYSIS 67
5.5 ECOSYSTEM ANALYSIS 68
5.6 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS 69
5.7 PRICING ANALYSIS 70
5.7.1 INDICATIVE SELLING PRICE OF HUMAN IDENTIFICATION PRODUCTS, BY TYPE, 2025 71
5.7.2 INDICATIVE SELLING PRICE OF HUMAN IDENTIFICATION PRODUCTS, BY REGION, 2025 72
5.8 TRADE ANALYSIS 73
5.8.1 IMPORT DATA FOR HS CODE 382200, 2021–2025 73
5.8.2 EXPORT DATA FOR HS CODE 382200, 2021–2025 74
5.8.3 IMPORT VOLUME FOR HS 382200, 2021–2025 74
5.8.4 EXPORT VOLUME FOR HS CODE 382200, 2021–2025 75
5.9 KEY CONFERENCES & EVENTS, 2026–2027 76
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77
5.11 INVESTMENT & FUNDING ACTIVITY 78
5.12 CASE STUDY ANALYSIS 78
5.13 IMPACT OF 2025 US TARIFFS ON HUMAN IDENTIFICATION MARKET 81
5.13.1 INTRODUCTION 81
5.13.2 KEY TARIFF RATES 81
5.13.3 PRICE IMPACT ANALYSIS 82
5.13.4 IMPACT ON COUNTRY/REGION 82
5.13.4.1 US 82
5.13.4.2 Europe 83
5.13.4.3 Asia Pacific 83
5.13.5 IMPACT ON END-USE INDUSTRIES 84
5.13.5.1 Forensic laboratories 84
5.13.5.2 Research centers and academic & government institutes 84
5.13.5.3 Other end users 85
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 86
6.1 TECHNOLOGY ANALYSIS 86
6.1.1 KEY TECHNOLOGIES 86
6.1.1.1 Polymerase chain reaction (PCR) 86
6.1.1.2 Capillary electrophoresis (CE) 86
6.1.1.3 Next-generation sequencing 86
6.1.2 COMPLEMENTARY TECHNOLOGIES 87
6.1.2.1 Biometric identification technologies 87
6.1.2.2 Anti-spoofing & trust layers 87
6.1.3 ADJACENT TECHNOLOGIES 87
6.1.3.1 Digital identity & identity proofing (civil/enterprise) 87
6.2 TECHNOLOGY/PRODUCT ROADMAP 87
6.3 PATENT ANALYSIS 89
6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR HUMAN IDENTIFICATION PRODUCT/TECHNOLOGY PATENTS, 2015–2025 89
6.4 FUTURE APPLICATIONS 90
6.5 IMPACT OF AI/GEN AI ON HUMAN IDENTIFICATION MARKET 91
6.5.1 TOP USE CASES & MARKET POTENTIAL 92
6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN HUMAN IDENTIFICATION MARKET 93
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 94
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN HUMAN IDENTIFICATION MARKET 94
6.6 SUCCESS STORIES & REAL-WORLD APPLICATIONS 95

7 SUSTAINABILITY & REGULATORY LANDSCAPE 96
7.1 REGULATORY LANDSCAPE 96
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
7.1.2 REGULATORY FRAMEWORK/KEY REGULATIONS 98
7.1.2.1 North America 98
7.1.2.1.1 US 98
7.1.2.1.2 Canada 100
7.1.2.2 Europe 102
7.1.2.3 Asia Pacific 103
7.1.2.3.1 Japan 103
7.1.2.3.2 China 104
7.1.2.3.3 India 104
7.1.2.3.4 South Korea 105
7.1.2.4 Latin America 106
7.1.2.4.1 Brazil 106
7.1.2.5 Middle East 106
7.1.2.5.1 Saudi Arabia 106
7.1.3 INDUSTRY STANDARDS 107
7.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 109
7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 110
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 111
8.1 DECISION-MAKING PROCESS 111
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 111
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 111
8.2.2 KEY BUYING CRITERIA, BY END USER 112
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 113
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 114
8.5 MARKET PROFITABILITY 115
9 HUMAN IDENTIFICATION MARKET, BY PRODUCT 116
9.1 INTRODUCTION 117
9.2 CONSUMABLES 117
9.2.1 DNA AMPLIFICATION KITS & REAGENTS 121
9.2.1.1 Increased demand for multiplex PCR assays to boost segmental growth 121
9.2.2 RAPID DNA ANALYSIS KITS & REAGENTS 124
9.2.2.1 Automated processing and reduced sample contamination to aid market growth 124
9.2.3 DNA QUANTIFICATION KITS & REAGENTS 127
9.2.3.1 Advancements in qPCR technology and growing need for faster human identification results to drive market growth 127
9.2.4 DNA EXTRACTION KITS & REAGENTS 130
9.2.4.1 Advancements in DNA extraction and purification technologies to propel market growth 130
9.3 INSTRUMENTS 133
9.3.1 SAMPLE PREPARATION & EXTRACTION SYSTEMS 136
9.3.1.1 Complete sample traceability and high process safety to drive market growth 136
9.3.2 DNA AMPLIFICATION SYSTEMS 139
9.3.2.1 Easy replication of specific DNA regions in forensic sciences to propel segmental growth 139
9.3.3 DNA ANALYSIS SYSTEMS 142
9.3.3.1 Greater efficacy and lesser turnaround time to augment growth 142
9.3.4 DNA QUANTIFICATION SYSTEMS 144
9.3.4.1 Effective analysis of DNA integrity and detection of PCR inhibitors to boost market growth 144
9.4 SOFTWARE 147
9.4.1 RISING VOLUME OF PROCEDURES AND INCREASING COMPLEXITY OF GENETIC DATA TO DRIVE MARKET 147
10 HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY 151
10.1 INTRODUCTION 152
10.2 POLYMERASE CHAIN REACTION 152
10.2.1 HIGHER SENSITIVITY AND LOWER TURNAROUND TIME DURING FORENSIC INVESTIGATIONS TO PROPEL MARKET GROWTH 152
10.3 CAPILLARY ELECTROPHORESIS 156
10.3.1 ACCURATE EXAMINATION OF GENETIC MARKERS AND ESTABLISHMENT OF BIOLOGICAL LINKS TO SUPPORT GROWTH 156
10.4 NEXT-GENERATION SEQUENCING 159
10.4.1 EASY IDENTIFICATION OF MIXED DNA SAMPLES AND ANALYSIS OF COMPLEX PATERNITY CASES TO AID MARKET GROWTH 159
10.5 MICROARRAYS 163
10.5.1 RAPID AND ACCURATE ANALYSIS OF LARGE SAMPLE SETS AT LOW COSTS TO AUGMENT MARKET GROWTH 163
10.6 RAPID DNA ANALYSIS 166
10.6.1 EFFECTIVE REAL-TIME SAMPLE ANALYSIS FOR DNA PROFILE CREATION TO PROPEL MARKET GROWTH 166
11 HUMAN IDENTIFICATION MARKET, BY APPLICATION 169
11.1 INTRODUCTION 170
11.2 FORENSICS 170
11.2.1 INCREASING CRIME RATE TO PROPEL GROWTH 170
11.3 PATERNITY TESTING 174
11.3.1 RISING NEED TO RESOLVE LEGAL AND PERSONAL DISPUTES TO SUPPORT MARKET GROWTH 174
11.4 OTHER APPLICATIONS 177
12 HUMAN IDENTIFICATION MARKET, BY END USER 181
12.1 INTRODUCTION 182
12.2 FORENSIC LABORATORIES 182
12.2.1 RISING CRIME RATE TO DRIVE DEMAND FOR HUMAN IDENTIFICATION SERVICES 182
12.3 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 186
12.3.1 ADVANCEMENTS IN GENOMICS RESEARCH TO DRIVE MARKET 186
12.4 OTHER END USERS 189
13 HUMAN IDENTIFICATION MARKET, BY REGION 193
13.1 INTRODUCTION 194
13.2 NORTH AMERICA 194
13.2.1 US 198
13.2.1.1 Rising crime rates and increasing government-funded initiatives for forensic programs to boost demand 198
13.2.2 CANADA 201
13.2.2.1 Improvements in forensic laboratory infrastructure to drive market 201
13.3 EUROPE 203
13.3.1 GERMANY 206
13.3.1.1 Stringent regulatory guidelines for forensic investigations to boost demand 206
13.3.2 UK 209
13.3.2.1 Growing availability of forensic equipment to propel market 209
13.3.3 FRANCE 211
13.3.3.1 Rising demand for tests to support market growth 211
13.3.4 ITALY 214
13.3.4.1 Advancements in DNA analysis to fuel market 214
13.3.5 SPAIN 216
13.3.5.1 Growing demand for gene expression analysis services to propel market 216
13.3.6 REST OF EUROPE 219
13.4 ASIA PACIFIC 221
13.4.1 CHINA 225
13.4.1.1 Rising establishment of forensic databases to drive market 225
13.4.2 JAPAN 227
13.4.2.1 High demand for DNA analysis kits to drive market 227
13.4.3 INDIA 229
13.4.3.1 Rising crime rates to boost demand 229
13.4.4 AUSTRALIA 232
13.4.4.1 Increasing adoption of DNA profiling across forensic science 232
13.4.5 SOUTH KOREA 234
13.4.5.1 Rapid modernization of national DNA infrastructure & advanced forensic technology adoption to support growth 234
13.4.6 REST OF ASIA PACIFIC 236
13.5 LATIN AMERICA 239
13.5.1 BRAZIL 241
13.5.1.1 Scale-up of national DNA databasing to support market growth 241
13.5.2 MEXICO 244
13.5.2.1 Increasing missing-person crisis in country to boost market 244
13.5.3 REST OF LATIN AMERICA 246
13.6 MIDDLE EAST 248
13.6.1 GCC COUNTRIES 251
13.6.1.1 Saudi Arabia 254
13.6.1.1.1 Convergence of national genomics investment and forensic capability building to propel market 254
13.6.1.2 UAE 256
13.6.1.2.1 Move beyond routine forensic DNA testing toward higher-value model built on automation to support growth 256
13.6.1.3 Rest of GCC Countries 259
13.6.1.3.1 Steady investments in forensic infrastructure and regional standardization efforts to boost market 259
13.6.2 REST OF MIDDLE EAST 261
13.7 AFRICA 263
13.7.1 LARGE AND UNDERADDRESSED NEED FOR FORENSIC IDENTIFICATION OF MISSING PERSONS TO FUEL GROWTH 263
14 COMPETITIVE LANDSCAPE 266
14.1 INTRODUCTION 266
14.2 STRATEGIES ADOPTED BY KEY PLAYERS 266
14.3 REVENUE ANALYSIS, 2021–2025 268
14.4 MARKET SHARE ANALYSIS, 2025 269
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 271
14.5.1 STARS 272
14.5.2 EMERGING LEADERS 272
14.5.3 PERVASIVE PLAYERS 272
14.5.4 PARTICIPANTS 272
14.5.5 COMPETITIVE BENCHMARKING: KEY PLAYERS, 2025 274
14.5.5.1 Company footprint 274
14.5.5.2 Region footprint 275
14.5.5.3 Product footprint 276
14.5.5.4 Technology footprint 277
14.5.5.5 Application footprint 278
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 279
14.6.1 PROGRESSIVE COMPANIES 279
14.6.2 RESPONSIVE COMPANIES 279
14.6.3 DYNAMIC COMPANIES 279
14.6.4 STARTING BLOCKS 279
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 281
14.6.5.1 Detailed list of key startups/SMEs, 2025 281
14.6.5.2 Competitive benchmarking of key startups/SMEs, 2025 282
14.7 COMPANY VALUATION & FINANCIAL METRICS 283
14.7.1 FINANCIAL METRICS 283
14.7.2 COMPANY VALUATION 283
14.8 BRAND/PRODUCT COMPARISON 284
14.9 COMPETITIVE SCENARIO 285
14.9.1 PRODUCT LAUNCHES 285
14.9.2 DEALS 286
15 COMPANY PROFILES 287
15.1 KEY PLAYERS 287
15.1.1 THERMO FISHER SCIENTIFIC INC. 287
15.1.1.1 Business overview 287
15.1.1.2 Products offered 288
15.1.1.3 MnM view 289
15.1.1.3.1 Key strengths 289
15.1.1.3.2 Strategic choices 289
15.1.1.3.3 Weaknesses & competitive threats 289
15.1.2 QIAGEN N.V. 290
15.1.2.1 Business overview 290
15.1.2.2 Products offered 291
15.1.2.3 Recent developments 292
15.1.2.3.1 Product launches & approvals 292
15.1.2.3.2 Deals 292
15.1.2.4 MnM view 293
15.1.2.4.1 Key strengths 293
15.1.2.4.2 Strategic choices 293
15.1.2.4.3 Weaknesses & competitive threats 293
15.1.3 PROMEGA CORPORATION 294
15.1.3.1 Business overview 294
15.1.3.2 Products offered 294
15.1.3.3 Recent developments 295
15.1.3.3.1 Product launches & approvals 295
15.1.3.4 MnM view 296
15.1.3.4.1 Key strengths 296
15.1.3.4.2 Strategic choices 296
15.1.3.4.3 Weaknesses & competitive threats 296

15.1.4 ANDE CORPORATION 297
15.1.4.1 Business overview 297
15.1.4.2 Products offered 297
15.1.4.3 MnM view 297
15.1.4.3.1 Key strengths 297
15.1.4.3.2 Strategic choices 298
15.1.4.3.3 Weaknesses & competitive threats 298
15.1.5 HAMILTON COMPANY 299
15.1.5.1 Business overview 299
15.1.5.2 Products offered 299
15.1.5.3 MnM view 300
15.1.5.3.1 Key strengths 300
15.1.5.3.2 Strategic choices 300
15.1.5.3.3 Weaknesses & competitive threats 300
15.1.6 FUJIFILM WAKO PURE CHEMICAL CORPORATION 301
15.1.6.1 Business overview 301
15.1.6.2 Products offered 301
15.1.7 AUTOGEN INC. 302
15.1.7.1 Business overview 302
15.1.7.2 Products offered 302
15.1.8 INNOGENOMICS TECHNOLOGIES, LLC 303
15.1.8.1 Business overview 303
15.1.8.2 Products offered 303
15.1.8.3 Recent developments 304
15.1.8.3.1 Product launches 304
15.1.9 OXFORD NANOPORE TECHNOLOGIES PLC 305
15.1.9.1 Business overview 305
15.1.9.2 Products offered 306
15.1.10 BODE CELLMARK FORENSICS, INC. 307
15.1.10.1 Business overview 307
15.1.10.2 Products offered 307
15.1.11 BIO-RAD LABORATORIES, INC. 308
15.1.11.1 Business overview 308
15.1.11.2 Products offered 309
15.1.12 ZEISS 310
15.1.12.1 Business overview 310
15.1.12.2 Products offered 311
15.1.13 CYBERGENETICS 312
15.1.13.1 Business overview 312
15.1.13.2 Products offered 312

15.1.14 MACHEREY-NAGEL GMBH & CO. KG 313
15.1.14.1 Business overview 313
15.1.14.2 Products offered 313
15.1.15 BIOTYPE 314
15.1.15.1 Business overview 314
15.1.15.2 Products offered 314
15.2 OTHER PLAYERS 315
15.2.1 OTHRAM INC. 315
15.2.2 GENETEK BIOPHARMA GMBH 315
15.2.3 CAROLINA BIOLOGICAL SUPPLY COMPANY 316
15.2.4 STRMIX LIMITED 316
15.2.5 NINGBO HEALTH GENE TECHNOLOGIES CO., LTD. 317
15.2.6 SOFTGENETICS 317
15.2.7 VERSATERM 318
15.2.8 GENO TECHNOLOGY INC. 318
15.2.9 COMPLETE GENOMICS INCORPORATED 319
15.2.10 BIONEER CORPORATION 319
15.2.11 ABNOVA CORPORATION 320
15.2.12 MGI TECH CO., LTD. 320
15.2.13 ULTIMA GENOMICS, INC. 321
15.2.14 ELEMENT BIOSCIENCES 321
15.2.15 SINGULAR GENOMICS SYSTEMS, INC. 322
15.2.16 WATCHMAKER GENOMICS 322
16 RESEARCH METHODOLOGY 323
16.1 RESEARCH DATA 323
16.1.1 SECONDARY DATA 324
16.1.1.1 Key data from secondary sources 324
16.1.2 PRIMARY DATA 325
16.1.2.1 Key data from primary sources 325
16.1.2.2 Key primary participants 325
16.1.2.3 Breakdown of primary interviews 326
16.1.2.4 Key industry insights 327
16.2 MARKET SIZE ESTIMATION 328
16.2.1 SEGMENTAL MARKET SIZE ESTIMATION 330
16.3 MARKET GROWTH RATE PROJECTIONS 332
16.4 FACTOR ANALYSIS 333
16.5 DATA TRIANGULATION 335
16.6 RESEARCH ASSUMPTIONS 336
16.7 RESEARCH LIMITATIONS & RISK ASSESSMENT 337
16.8 RISK ASSESSMENT 337
17 APPENDIX 338
17.1 DISCUSSION GUIDE 338
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 341
17.3 CUSTOMIZATION OPTIONS 343
17.4 RELATED REPORTS 343
17.5 AUTHOR DETAILS 344

LIST OF TABLES

TABLE 1 HUMAN IDENTIFICATION MARKET: IMPACT ANALYSIS 49
TABLE 2 TOTAL NUMBER OF FORENSIC PROFILES IN US, 2023–2025 50
TABLE 3 NEXT-GENERATION SEQUENCING MARKET, BY REGION,
2024–2031 (USD MILLION) 57
TABLE 4 HUMAN IDENTIFICATION MARKET: PORTER’S FIVE FORCES ANALYSIS 60
TABLE 5 HEALTH EXPENDITURE AND FINANCING, 2015–2024 (% OF GDP) 64
TABLE 6 HUMAN IDENTIFICATION MARKET: ROLE IN ECOSYSTEM 68
TABLE 7 INDICATIVE SELLING PRICE OF HUMAN IDENTIFICATION PRODUCTS,
BY TYPE, 2025 71
TABLE 8 INDICATIVE SELLING PRICE OF HUMAN IDENTIFICATION PRODUCTS,
BY REGION, 2025 72
TABLE 9 IMPORT DATA FOR HS CODE 382200, BY COUNTRY,
2021–2025 (USD THOUSAND) 73
TABLE 10 EXPORT DATA FOR HS CODE 382200, BY COUNTRY,
2021–2025 (USD THOUSAND) 74
TABLE 11 IMPORT VOLUME FOR HS CODE 382200, BY COUNTRY, 2021–2025 (TONS) 74
TABLE 12 EXPORT VOLUME FOR HS CODE 382200, BY COUNTRY, 2021–2025 (TONS) 75
TABLE 13 HUMAN IDENTIFICATION MARKET: KEY CONFERENCES & EVENTS, 2026–2027 76
TABLE 14 CASE STUDY 1: RAPID DNA FOR INVESTIGATIVE LEADS IN PROPERTY CRIME & ROBBERY CASES 78
TABLE 15 CASE STUDY 2: SEXUAL ASSAULT EVIDENCE SCREENING THROUGH FORENSIC MICROSCOPY AND AI-ASSISTED SPERM DETECTION 79
TABLE 16 CASE STUDY 3: FORENSIC GENETIC GENEALOGY FOR UNIDENTIFIED REMAINS AND LONG-UNRESOLVED CASES 79
TABLE 17 CASE STUDY 4: BOOKING-STATION RAPID DNA FOR ARRESTEE PROCESSING AND DATABASE SEARCH 80
TABLE 18 CASE STUDY 5: SOLVING CHALLENGING SEXUAL ASSAULT CASES THROUGH EXPANDED Y-STR ANALYSIS 80
TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES 81
TABLE 20 HUMAN IDENTIFICATION MARKET: TECHNOLOGY/PRODUCT ROADMAP 88
TABLE 21 DETAILED ANALYSIS OF KEY PATENTS IN HUMAN IDENTIFICATION MARKET 90
TABLE 22 CASE STUDIES OF AI IMPLEMENTATION IN HUMAN IDENTIFICATION MARKET 93
TABLE 23 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN HUMAN IDENTIFICATION MARKET 95
TABLE 24 KEY SUCCESS STORIES & REAL-WORLD APPLICATIONS OF HUMAN IDENTIFICATION MARKET 95
TABLE 25 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 26 US FDA: MEDICAL DEVICE CLASSIFICATION 99
TABLE 27 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 99
TABLE 28 EUROPE: CLASSIFICATION OF IVD DEVICES 102
TABLE 29 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 103
TABLE 30 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 104
TABLE 31 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 105
TABLE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%) 112
TABLE 33 KEY BUYING CRITERIA, BY END USER 112
TABLE 34 UNMET NEEDS ACROSS DIFFERENT END USERS IN HUMAN IDENTIFICATION MARKET 114
TABLE 35 HUMAN IDENTIFICATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 117
TABLE 36 HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 118
TABLE 37 HUMAN IDENTIFICATION CONSUMABLES MARKET, BY REGION,
2024–2031 (USD MILLION) 118
TABLE 38 NORTH AMERICA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118
TABLE 39 EUROPE: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 119
TABLE 40 ASIA PACIFIC: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 41 LATIN AMERICA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120
TABLE 42 MIDDLE EAST: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 120
TABLE 43 GCC COUNTRIES: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120
TABLE 44 DNA AMPLIFICATION KITS & REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 121
TABLE 45 NORTH AMERICA: DNA AMPLIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121
TABLE 46 EUROPE: DNA AMPLIFICATION KITS & REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 122
TABLE 47 ASIA PACIFIC: DNA AMPLIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 122
TABLE 48 LATIN AMERICA: DNA AMPLIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 49 MIDDLE EAST: DNA AMPLIFICATION KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 123
TABLE 50 GCC COUNTRIES: DNA AMPLIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 51 RAPID DNA ANALYSIS KITS & REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 124
TABLE 52 NORTH AMERICA: RAPID DNA ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 53 EUROPE: RAPID DNA ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 125
TABLE 54 ASIA PACIFIC: RAPID DNA ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 55 LATIN AMERICA: RAPID DNA ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 56 MIDDLE EAST: RAPID DNA ANALYSIS KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 126
TABLE 57 GCC COUNTRIES: RAPID DNA ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 58 DNA QUANTIFICATION KITS & REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 127
TABLE 59 NORTH AMERICA: DNA QUANTIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 60 EUROPE: DNA QUANTIFICATION KITS & REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 128
TABLE 61 ASIA PACIFIC: DNA QUANTIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128
TABLE 62 LATIN AMERICA: DNA QUANTIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 63 MIDDLE EAST: DNA QUANTIFICATION KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 129
TABLE 64 GCC COUNTRIES: DNA QUANTIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 65 DNA EXTRACTION KITS & REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 130
TABLE 66 NORTH AMERICA: DNA EXTRACTION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 67 EUROPE: DNA EXTRACTION KITS & REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 131
TABLE 68 ASIA PACIFIC: DNA EXTRACTION KITS & REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 131
TABLE 69 LATIN AMERICA: DNA EXTRACTION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 70 MIDDLE EAST: DNA EXTRACTION KITS & REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 132
TABLE 71 GCC COUNTRIES: DNA EXTRACTION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 72 HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 133
TABLE 73 HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 133
TABLE 74 NORTH AMERICA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 75 EUROPE: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 134
TABLE 76 ASIA PACIFIC: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 77 LATIN AMERICA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 135
TABLE 78 MIDDLE EAST: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 135
TABLE 79 GCC COUNTRIES: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136
TABLE 80 SAMPLE PREPARATION & EXTRACTION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 136
TABLE 81 NORTH AMERICA: SAMPLE PREPARATION & EXTRACTION SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 82 EUROPE: SAMPLE PREPARATION & EXTRACTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 83 ASIA PACIFIC: SAMPLE PREPARATION & EXTRACTION SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 138
TABLE 84 LATIN AMERICA: SAMPLE PREPARATION & EXTRACTION SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 138
TABLE 85 MIDDLE EAST: SAMPLE PREPARATION & EXTRACTION SYSTEMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 138
TABLE 86 GCC COUNTRIES: SAMPLE PREPARATION & EXTRACTION SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 87 DNA AMPLIFICATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 139
TABLE 88 NORTH AMERICA: DNA AMPLIFICATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 140
TABLE 89 EUROPE: DNA AMPLIFICATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 140
TABLE 90 ASIA PACIFIC: DNA AMPLIFICATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 141
TABLE 91 LATIN AMERICA: DNA AMPLIFICATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 141
TABLE 92 MIDDLE EAST: DNA AMPLIFICATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 141
TABLE 93 GCC COUNTRIES: DNA AMPLIFICATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 142
TABLE 94 DNA ANALYSIS SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 142
TABLE 95 NORTH AMERICA: DNA ANALYSIS SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 143
TABLE 96 EUROPE: DNA ANALYSIS SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 143
TABLE 97 ASIA PACIFIC: DNA ANALYSIS SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 143
TABLE 98 LATIN AMERICA: DNA ANALYSIS SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 144
TABLE 99 MIDDLE EAST: DNA ANALYSIS SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 144
TABLE 100 GCC COUNTRIES: DNA ANALYSIS SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 144
TABLE 101 DNA QUANTIFICATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 145
TABLE 102 NORTH AMERICA: DNA QUANTIFICATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 145
TABLE 103 EUROPE: DNA QUANTIFICATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 145
TABLE 104 ASIA PACIFIC: DNA QUANTIFICATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 146
TABLE 105 LATIN AMERICA: DNA QUANTIFICATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 146
TABLE 106 MIDDLE EAST: DNA QUANTIFICATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 146
TABLE 107 GCC COUNTRIES: DNA QUANTIFICATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 108 HUMAN IDENTIFICATION SOFTWARE MARKET, BY REGION,
2024–2031 (USD MILLION) 148
TABLE 109 NORTH AMERICA: HUMAN IDENTIFICATION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 110 EUROPE: HUMAN IDENTIFICATION SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 148
TABLE 111 ASIA PACIFIC: HUMAN IDENTIFICATION SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 149
TABLE 112 LATIN AMERICA: HUMAN IDENTIFICATION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 113 MIDDLE EAST: HUMAN IDENTIFICATION SOFTWARE MARKET, BY REGION,
2024–2031 (USD MILLION) 149
TABLE 114 GCC COUNTRIES: HUMAN IDENTIFICATION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 115 HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 152
TABLE 116 HUMAN IDENTIFICATION MARKET FOR POLYMERASE CHAIN REACTION,
BY REGION, 2024–2031 (USD MILLION) 153
TABLE 117 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 118 EUROPE: HUMAN IDENTIFICATION MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2024–2031 (USD MILLION) 154
TABLE 119 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2024–2031 (USD MILLION) 154
TABLE 120 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 121 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2024–2031 (USD MILLION) 155
TABLE 122 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 123 HUMAN IDENTIFICATION MARKET FOR CAPILLARY ELECTROPHORESIS, BY REGION, 2024–2031 (USD MILLION) 156
TABLE 124 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 125 EUROPE: HUMAN IDENTIFICATION MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 126 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 127 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 128 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR CAPILLARY ELECTROPHORESIS, BY REGION, 2024–2031 (USD MILLION) 158
TABLE 129 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 130 HUMAN IDENTIFICATION MARKET FOR NEXT-GENERATION SEQUENCING,
BY REGION, 2024–2031 (USD MILLION) 160
TABLE 131 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 160
TABLE 132 EUROPE: HUMAN IDENTIFICATION MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 161
TABLE 133 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 161
TABLE 134 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 162
TABLE 135 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 162
TABLE 136 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 162
TABLE 137 HUMAN IDENTIFICATION MARKET FOR MICROARRAYS, BY REGION,
2024–2031 (USD MILLION) 163
TABLE 138 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR MICROARRAYS,
BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 139 EUROPE: HUMAN IDENTIFICATION MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 140 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 141 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR MICROARRAYS,
BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 142 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR MICROARRAYS, BY REGION, 2024–2031 (USD MILLION) 165
TABLE 143 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR MICROARRAYS,
BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 144 HUMAN IDENTIFICATION MARKET FOR RAPID DNA ANALYSIS, BY REGION,
2024–2031 (USD MILLION) 166
TABLE 145 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR RAPID DNA ANALYSIS,
BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 146 EUROPE: HUMAN IDENTIFICATION MARKET FOR RAPID DNA ANALYSIS,
BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 147 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR RAPID DNA ANALYSIS,
BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 148 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR RAPID DNA ANALYSIS,
BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 149 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR RAPID DNA ANALYSIS,
BY REGION, 2024–2031 (USD MILLION) 168
TABLE 150 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR RAPID DNA ANALYSIS,
BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 151 HUMAN IDENTIFICATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 170
TABLE 152 NORTH AMERICA: CRIME RATE COMPARISONS, BY REGION, 2024 VS. 2025 171
TABLE 153 HUMAN IDENTIFICATION MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 171
TABLE 154 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 155 EUROPE: HUMAN IDENTIFICATION MARKET FOR FORENSIC APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 156 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR FORENSIC APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 157 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 158 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 173
TABLE 159 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 160 HUMAN IDENTIFICATION MARKET FOR PATERNITY TESTING, BY REGION,
2024–2031 (USD MILLION) 174
TABLE 161 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR PATERNITY TESTING,
BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 162 EUROPE: HUMAN IDENTIFICATION MARKET FOR PATERNITY TESTING,
BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 163 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR PATERNITY TESTING,
BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 164 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR PATERNITY TESTING,
BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 165 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR PATERNITY TESTING,
BY REGION, 2024–2031 (USD MILLION) 176
TABLE 166 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR PATERNITY TESTING,
BY COUNTRY, 2024–2031 (USD MILLION) 177
TABLE 167 HUMAN IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION,
2024–2031 (USD MILLION) 178
TABLE 168 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 169 EUROPE: HUMAN IDENTIFICATION MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 170 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 171 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 172 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR OTHER APPLICATIONS,
BY REGION, 2024–2031 (USD MILLION) 180
TABLE 173 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 174 HUMAN IDENTIFICATION MARKET, BY END USER, 2024–2031 (USD MILLION) 182
TABLE 175 HUMAN IDENTIFICATION MARKET FOR FORENSIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 183
TABLE 176 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 177 EUROPE: HUMAN IDENTIFICATION MARKET FOR FORENSIC LABORATORIES,
BY COUNTRY, 2024–2031 (USD MILLION) 184
TABLE 178 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 184
TABLE 179 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 180 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR FORENSIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 185
TABLE 181 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 182 HUMAN IDENTIFICATION MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 186
TABLE 183 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY,
2024–2031 (USD MILLION) 187
TABLE 184 EUROPE: HUMAN IDENTIFICATION MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY,
2024–2031 (USD MILLION) 187
TABLE 185 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY,
2024–2031 (USD MILLION) 188
TABLE 186 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY,
2024–2031 (USD MILLION) 188
TABLE 187 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 188
TABLE 188 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY,
2024–2031 (USD MILLION) 189
TABLE 189 HUMAN IDENTIFICATION MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 189
TABLE 190 NORTH AMERICA: HUMAN IDENTIFICATION MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 190
TABLE 191 EUROPE: HUMAN IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 190
TABLE 192 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 193 LATIN AMERICA: HUMAN IDENTIFICATION MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 194 MIDDLE EAST: HUMAN IDENTIFICATION MARKET FOR OTHER END USERS,
BY REGION, 2024–2031 (USD MILLION) 191
TABLE 195 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 192
TABLE 196 HUMAN IDENTIFICATION MARKET, BY REGION, 2024–2031 (USD MILLION) 194
TABLE 197 NORTH AMERICA: HUMAN IDENTIFICATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 195
TABLE 198 NORTH AMERICA: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 196
TABLE 199 NORTH AMERICA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 200 NORTH AMERICA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 201 NORTH AMERICA: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 197
TABLE 202 NORTH AMERICA: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 197
TABLE 203 NORTH AMERICA: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 198
TABLE 204 US: HUMAN IDENTIFICATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 198
TABLE 205 US: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 206 US: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 207 US: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 200
TABLE 208 US: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 200
TABLE 209 US: HUMAN IDENTIFICATION MARKET, BY END USER, 2024–2031 (USD MILLION) 200
TABLE 210 CANADA: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 201
TABLE 211 CANADA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 202
TABLE 212 CANADA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 202
TABLE 213 CANADA: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 202
TABLE 214 CANADA: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 203
TABLE 215 CANADA: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 203
TABLE 216 EUROPE: HUMAN IDENTIFICATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 204
TABLE 217 EUROPE: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 204
TABLE 218 EUROPE: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 204
TABLE 219 EUROPE: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 220 EUROPE: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 205
TABLE 221 EUROPE: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 205
TABLE 222 EUROPE: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 206
TABLE 223 GERMANY: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 207
TABLE 224 GERMANY: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 207
TABLE 225 GERMANY: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 207
TABLE 226 GERMANY: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 208
TABLE 227 GERMANY: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 208
TABLE 228 GERMANY: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 208
TABLE 229 UK: HUMAN IDENTIFICATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 209
TABLE 230 UK: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 231 UK: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 232 UK: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 210
TABLE 233 UK: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 211
TABLE 234 UK: HUMAN IDENTIFICATION MARKET, BY END USER, 2024–2031 (USD MILLION) 211
TABLE 235 FRANCE: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 212
TABLE 236 FRANCE: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 212
TABLE 237 FRANCE: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 212
TABLE 238 FRANCE: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 213
TABLE 239 FRANCE: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 213
TABLE 240 FRANCE: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 213
TABLE 241 ITALY: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 214
TABLE 242 ITALY: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 243 ITALY: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 244 ITALY: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 215
TABLE 245 ITALY: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 216
TABLE 246 ITALY: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 216
TABLE 247 SPAIN: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 217
TABLE 248 SPAIN: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 217
TABLE 249 SPAIN: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 217
TABLE 250 SPAIN: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 218
TABLE 251 SPAIN: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 218
TABLE 252 SPAIN: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 218
TABLE 253 REST OF EUROPE: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 219
TABLE 254 REST OF EUROPE: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 255 REST OF EUROPE: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 220
TABLE 256 REST OF EUROPE: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 220
TABLE 257 REST OF EUROPE: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 220
TABLE 258 REST OF EUROPE: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 221
TABLE 259 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 222
TABLE 260 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 223
TABLE 261 ASIA PACIFIC: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 223
TABLE 262 ASIA PACIFIC: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 223
TABLE 263 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 224
TABLE 264 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 224
TABLE 265 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 224
TABLE 266 CHINA: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 225
TABLE 267 CHINA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 225
TABLE 268 CHINA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 226
TABLE 269 CHINA: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 226
TABLE 270 CHINA: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 226
TABLE 271 CHINA: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 227
TABLE 272 JAPAN: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 227
TABLE 273 JAPAN: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 228
TABLE 274 JAPAN: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 228
TABLE 275 JAPAN: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 228
TABLE 276 JAPAN: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 229
TABLE 277 JAPAN: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 229
TABLE 278 INDIA: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 230
TABLE 279 INDIA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 230
TABLE 280 INDIA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 230
TABLE 281 INDIA: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 231
TABLE 282 INDIA: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 231
TABLE 283 INDIA: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 231
TABLE 284 AUSTRALIA: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 232
TABLE 285 AUSTRALIA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 232
TABLE 286 AUSTRALIA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 287 AUSTRALIA: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 233
TABLE 288 AUSTRALIA: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 233
TABLE 289 AUSTRALIA: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 234
TABLE 290 SOUTH KOREA: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 234
TABLE 291 SOUTH KOREA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 235
TABLE 292 SOUTH KOREA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 235
TABLE 293 SOUTH KOREA: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 235
TABLE 294 SOUTH KOREA: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 236
TABLE 295 SOUTH KOREA: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 236
TABLE 296 REST OF ASIA PACIFIC: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 237
TABLE 297 REST OF ASIA PACIFIC: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 298 REST OF ASIA PACIFIC: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 299 REST OF ASIA PACIFIC: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 238
TABLE 300 REST OF ASIA PACIFIC: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 238
TABLE 301 REST OF ASIA PACIFIC: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 238
TABLE 302 LATIN AMERICA: HUMAN IDENTIFICATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 239
TABLE 303 LATIN AMERICA: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 239
TABLE 304 LATIN AMERICA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 305 LATIN AMERICA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 306 LATIN AMERICA: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 240
TABLE 307 LATIN AMERICA: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 241
TABLE 308 LATIN AMERICA: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 241
TABLE 309 BRAZIL: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 242
TABLE 310 BRAZIL: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 242
TABLE 311 BRAZIL: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 242
TABLE 312 BRAZIL: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 243
TABLE 313 BRAZIL: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 243
TABLE 314 BRAZIL: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 243
TABLE 315 MEXICO: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 244
TABLE 316 MEXICO: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 244
TABLE 317 MEXICO: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 318 MEXICO: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 245
TABLE 319 MEXICO: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 245
TABLE 320 MEXICO: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 246
TABLE 321 REST OF LATIN AMERICA: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 246
TABLE 322 REST OF LATIN AMERICA: HUMAN IDENTIFICATION CONSUMABLES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 323 REST OF LATIN AMERICA: HUMAN IDENTIFICATION INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 324 REST OF LATIN AMERICA: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 247
TABLE 325 REST OF LATIN AMERICA: HUMAN IDENTIFICATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 248
TABLE 326 REST OF LATIN AMERICA: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 248
TABLE 327 MIDDLE EAST: HUMAN IDENTIFICATION MARKET, BY REGION,
2024–2031 (USD MILLION) 249
TABLE 328 MIDDLE EAST: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 249
TABLE 329 MIDDLE EAST: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 249
TABLE 330 MIDDLE EAST: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 250
TABLE 331 MIDDLE EAST: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 250
TABLE 332 MIDDLE EAST: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 250
TABLE 333 MIDDLE EAST: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 251
TABLE 334 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 251
TABLE 335 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 252
TABLE 336 GCC COUNTRIES: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 337 GCC COUNTRIES: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 338 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 253
TABLE 339 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 253
TABLE 340 GCC COUNTRIES: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 253
TABLE 341 SAUDI ARABIA: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 254
TABLE 342 SAUDI ARABIA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 343 SAUDI ARABIA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 344 SAUDI ARABIA: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 255
TABLE 345 SAUDI ARABIA: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 256
TABLE 346 SAUDI ARABIA: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 256
TABLE 347 UAE: HUMAN IDENTIFICATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 257
TABLE 348 UAE: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 349 UAE: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 350 UAE: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 258
TABLE 351 UAE: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 258
TABLE 352 UAE: HUMAN IDENTIFICATION MARKET, BY END USER, 2024–2031 (USD MILLION) 258
TABLE 353 REST OF GCC COUNTRIES: HUMAN IDENTIFICATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 259
TABLE 354 REST OF GCC COUNTRIES: HUMAN IDENTIFICATION CONSUMABLES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 355 REST OF GCC COUNTRIES: HUMAN IDENTIFICATION INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 260
TABLE 356 REST OF GCC COUNTRIES: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 260
TABLE 357 REST OF GCC COUNTRIES: HUMAN IDENTIFICATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 260
TABLE 358 REST OF GCC COUNTRIES: HUMAN IDENTIFICATION MARKET, BY END USER, 2024–2031 (USD MILLION) 261
TABLE 359 REST OF MIDDLE EAST: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 261
TABLE 360 REST OF MIDDLE EAST: HUMAN IDENTIFICATION CONSUMABLES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 361 REST OF MIDDLE EAST: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 362 REST OF MIDDLE EAST: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 262
TABLE 363 REST OF MIDDLE EAST: HUMAN IDENTIFICATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 263
TABLE 364 REST OF MIDDLE EAST: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 263
TABLE 365 AFRICA: HUMAN IDENTIFICATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 264
TABLE 366 AFRICA: HUMAN IDENTIFICATION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 367 AFRICA: HUMAN IDENTIFICATION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 368 AFRICA: HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 265
TABLE 369 AFRICA: HUMAN IDENTIFICATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 265
TABLE 370 AFRICA: HUMAN IDENTIFICATION MARKET, BY END USER,
2024–2031 (USD MILLION) 265
TABLE 371 STRATEGIES ADOPTED BY KEY PLAYERS IN HUMAN IDENTIFICATION MARKET, 2023−2026 266
TABLE 372 HUMAN IDENTIFICATION MARKET: DEGREE OF COMPETITION 270
TABLE 373 HUMAN IDENTIFICATION MARKET: REGION FOOTPRINT 275
TABLE 374 HUMAN IDENTIFICATION MARKET: PRODUCT FOOTPRINT 276
TABLE 375 HUMAN IDENTIFICATION MARKET: TECHNOLOGY FOOTPRINT 277
TABLE 376 HUMAN IDENTIFICATION MARKET: APPLICATION FOOTPRINT 278
TABLE 377 HUMAN IDENTIFICATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025 281
TABLE 378 HUMAN IDENTIFICATION: COMPETITIVE BENCHMARKING OF KEY
STARTUPS/SMES, 2025 282
TABLE 379 HUMAN IDENTIFICATION MARKET: PRODUCT LAUNCHES/APPROVALS,
JANUARY 2023–MARCH 2026 285
TABLE 380 HUMAN IDENTIFICATION MARKET: DEALS, JANUARY 2023– MARCH 2026 286
TABLE 381 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 287
TABLE 382 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 288
TABLE 383 QIAGEN N.V.: COMPANY OVERVIEW 290
TABLE 384 QIAGEN N.V.: PRODUCTS OFFERED 291
TABLE 385 QIAGEN N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MARCH 2026 292
TABLE 386 QIAGEN N.V.: DEALS, JANUARY 2023–MARCH 2026 292
TABLE 387 PROMEGA CORPORATION: COMPANY OVERVIEW 294
TABLE 388 PROMEGA CORPORATION: PRODUCTS OFFERED 294
TABLE 389 PROMEGA CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–MARCH 2026 295
TABLE 390 ANDE CORPORATION: COMPANY OVERVIEW 297
TABLE 391 ANDE CORPORATION: PRODUCTS OFFERED 297
TABLE 392 HAMILTON COMPANY: COMPANY OVERVIEW 299
TABLE 393 HAMILTON COMPANY: PRODUCTS OFFERED 299
TABLE 394 FUJIFILM WAKO PURE CHEMICAL CORPORATION: COMPANY OVERVIEW 301
TABLE 395 FUJIFILM WAKO PURE CHEMICAL CORPORATION: PRODUCTS OFFERED 301
TABLE 396 AUTOGEN INC.: COMPANY OVERVIEW 302
TABLE 397 AUTOGEN INC.: PRODUCTS OFFERED 302
TABLE 398 INNOGENOMICS TECHNOLOGIES, LLC: COMPANY OVERVIEW 303
TABLE 399 INNOGENOMICS TECHNOLOGIES, LLC: PRODUCTS OFFERED 303
TABLE 400 INNOGENOMICS TECHNOLOGIES, LLC: PRODUCT LAUNCHES,
JANUARY 2023–MARCH 2026 304
TABLE 401 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW 305
TABLE 402 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS OFFERED 306
TABLE 403 BODE CELLMARK FORENSICS, INC.: COMPANY OVERVIEW 307
TABLE 404 BODE CELLMARK FORENSICS, INC.: PRODUCTS OFFERED 307
TABLE 405 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 308
TABLE 406 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 309
TABLE 407 ZEISS: COMPANY OVERVIEW 310
TABLE 408 ZEISS: PRODUCTS OFFERED 311
TABLE 409 CYBERGENETICS: COMPANY OVERVIEW 312
TABLE 410 CYBERGENETICS: PRODUCTS OFFERED 312
TABLE 411 MACHEREY-NAGEL GMBH & CO. KG: COMPANY OVERVIEW 313
TABLE 412 MACHEREY-NAGEL GMBH & CO. KG: PRODUCTS OFFERED 313
TABLE 413 BIOTYPE: COMPANY OVERVIEW 314
TABLE 414 BIOTYPE: PRODUCTS OFFERED 314
TABLE 415 OTHRAM INC.: COMPANY OVERVIEW 315
TABLE 416 GENETEK BIOPHARMA GMBH: COMPANY OVERVIEW 315
TABLE 417 CAROLINA BIOLOGICAL SUPPLY COMPANY: COMPANY OVERVIEW 316
TABLE 418 STRMIX LIMITED: COMPANY OVERVIEW 316
TABLE 419 NINGBO HEALTH GENE TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 317
TABLE 420 SOFTGENETICS: COMPANY OVERVIEW 317
TABLE 421 VERSATERM: COMPANY OVERVIEW 318
TABLE 422 GENO TECHNOLOGY INC.: COMPANY OVERVIEW 318
TABLE 423 COMPLETE GENOMICS INCORPORATED: COMPANY OVERVIEW 319
TABLE 424 BIONEER CORPORATION: COMPANY OVERVIEW 319
TABLE 425 ABNOVA CORPORATION: COMPANY OVERVIEW 320
TABLE 426 MGI TECH CO., LTD.: COMPANY OVERVIEW 320
TABLE 427 ULTIMA GENOMICS, INC.: COMPANY OVERVIEW 321
TABLE 428 ELEMENT BIOSCIENCES: COMPANY OVERVIEW 321
TABLE 429 SINGULAR GENOMICS SYSTEMS, INC.: COMPANY OVERVIEW 322
TABLE 430 WATCHMAKER GENOMICS: COMPANY OVERVIEW 322
TABLE 431 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 333
TABLE 432 HUMAN IDENTIFICATION MARKET: RISK ANALYSIS 337

LIST OF FIGURES

FIGURE 1 HUMAN IDENTIFICATION MARKET SEGMENTATION & REGIONAL SCOPE 35
FIGURE 2 HUMAN IDENTIFICATION MARKET: YEARS CONSIDERED 36
FIGURE 3 MARKET SCENARIO 39
FIGURE 4 GLOBAL HUMAN IDENTIFICATION MARKET, 2024–2031 40
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HUMAN IDENTIFICATION MARKET, 2023–2026 41
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF HUMAN IDENTIFICATION MARKET 42
FIGURE 7 HIGH-GROWTH SEGMENTS IN HUMAN IDENTIFICATION MARKET, 2026–2031 43
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HUMAN IDENTIFICATION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 44
FIGURE 9 ADVANCEMENTS IN HID PLATFORMS TO DRIVE MARKET GROWTH 45
FIGURE 10 PRODUCTS ACCOUNTED FOR LARGEST SHARE OF HUMAN IDENTIFICATION MARKET IN NORTH AMERICA IN 2025 46
FIGURE 11 ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL HUMAN IDENTIFICATION MARKET DURING FORECAST PERIOD 47
FIGURE 12 FORENSIC LABORATORIES TO DOMINATE MARKET DURING FORECAST PERIOD 47
FIGURE 13 HUMAN IDENTIFICATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 48
FIGURE 14 HUMAN IDENTIFICATION MARKET: PORTER’S FIVE FORCES ANALYSIS 60
FIGURE 15 HUMAN IDENTIFICATION MARKET: VALUE CHAIN ANALYSIS 65
FIGURE 16 HUMAN IDENTIFICATION MARKET: SUPPLY CHAIN ANALYSIS 67
FIGURE 17 HUMAN IDENTIFICATION MARKET: ECOSYSTEM ANALYSIS 68
FIGURE 18 INDICATIVE SELLING PRICE OF HUMAN IDENTIFICATION PRODUCTS,
BY TYPE, 2025 72
FIGURE 19 HUMAN IDENTIFICATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77
FIGURE 20 KEY INVESTMENT AND FUNDING ACTIVITIES IN HUMAN IDENTIFICATION MARKET 78
FIGURE 21 TOP APPLICANTS/OWNERS (COMPANIES) FOR HUMAN IDENTIFICATION PRODUCTS/TECHNOLOGY PATENTS, 2015–2025 89
FIGURE 22 IMPACT OF AI/GEN AI ON HUMAN IDENTIFICATION MARKET 91
FIGURE 23 CANADA: REGULATORY PROCESS FOR IVD DEVICES 101
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PROCESS 111
FIGURE 25 KEY BUYING CRITERIA, BY END USER 112
FIGURE 26 NORTH AMERICA: HUMAN IDENTIFICATION MARKET SNAPSHOT 195
FIGURE 27 ASIA PACIFIC: HUMAN IDENTIFICATION MARKET SNAPSHOT 222
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN HUMAN IDENTIFICATION MARKET,
2021–2025 (USD MILLION) 268
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HUMAN IDENTIFICATION MARKET (2025) 270
FIGURE 30 HUMAN IDENTIFICATION MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 273
FIGURE 31 HUMAN IDENTIFICATION MARKET: COMPANY FOOTPRINT 274
FIGURE 32 HUMAN IDENTIFICATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 280
FIGURE 33 EV/EBITDA OF KEY VENDORS 283
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 283
FIGURE 35 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT 284
FIGURE 36 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 288
FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT (2025) 291
FIGURE 38 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2025) 306
FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 309
FIGURE 40 ZEISS: COMPANY SNAPSHOT (2025) 311
FIGURE 41 HUMAN IDENTIFICATION MARKET: RESEARCH DESIGN 323
FIGURE 42 HUMAN IDENTIFICATION MARKET: BREAKDOWN OF PRIMARIES 326
FIGURE 43 HUMAN IDENTIFICATION MARKET: INSIGHTS FROM PRIMARIES 327
FIGURE 44 GLOBAL HUMAN IDENTIFICATION MARKET ESTIMATION
(SUPPLY-SIDE ANALYSIS), 2025 328
FIGURE 45 HUMAN IDENTIFICATION MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025) 329
FIGURE 46 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.:
REVENUE ANALYSIS (2025) 329
FIGURE 47 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 331
FIGURE 48 HUMAN IDENTIFICATION MARKET: CAGR PROJECTIONS 332
FIGURE 49 HUMAN IDENTIFICATION MARKET: DATA TRIANGULATION 335

---

---